The Pennant Group, Inc.

PNTG Healthcare Medical Care Facilities

The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.8%, EPS grew 23.8%, free cash flow fell 50.9% and total debt rose 433.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

41.80 0.47 −1.11%
Market cap
$1.5B
P/E
44.5×
Fwd P/E
26.9×
Dividend yield
—
F-score
5/9
Altman Z
2.29
Beneish M
−2.52
Dividend safety
n/a

The Pennant Group, Inc. (PNTG) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, The Pennant Group, Inc. (PNTG) trades at a P/E ratio of 44.5×. Over the past ten years it has ranged from 0.0× (September 2022) to 452× (November 2022); the current reading is higher than 46% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 32.4× (12.15%)
FY2024 36.8× 16.73%
FY2023 31.6× (32.67%)
FY2022 46.9× (83.75%)
FY2021 289× 183.23%
FY2020 102× (67.41%)
FY2019 313× 737.67%
FY2018 37.3× 0.00%
FY2017 37.3× 0.00%
FY2016 37.3× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 39.3× 14.78%
Mar 2026 34.2× 5.84%
Dec 2025 32.4× 1.35%
Sep 2025 31.9× (13.37%)
27 more quarters

Against its own ten years

Low 0.0× High 452×
Ten-year median 47.6×
Current reading's percentile 44

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PNTG